封面
市場調查報告書
商品編碼
1401788

抗感染劑市場,按類型、管理途徑、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Anti-Infective Agents Market, By Type, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年抗感染藥物市場規模為1,374.6103億美元,2023年至2030年複合CAGR為4.2%。

抗感染劑市場-市場動態

傳染病病率和健康意識的提高推動市場需求

由於人們對傳染病診斷的可用性以及與早期診斷相關的可預防風險的健康意識不斷增強,預計抗感染藥物市場也將成長。細菌、病毒和真菌感染等傳染病繼續影響全世界更多的人。為了對抗這些疾病,現在更需要有效的抗感染藥物。由於新型傳染病的出現或舊傳染病的死灰復燃,有效的抗感染藥物變得越來越必要。這些疾病的一些例子包括最近的 COVID-19 大流行,以及伊波拉和寨卡病毒的爆發。這些事件表明,制定和實施有效的補救措施來控制和治療這些疾病是多麼緊迫。

抗感染藥物市場-關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2023-2030 年)每年將以 4.2% 左右的CAGR成長

根據類型細分,由於抗病毒藥物的開發不斷成長,預計抗病毒藥物將在 2022 年顯示最大的市場佔有率。

根據給藥途徑細分,口服給藥是 2022 年的主導類型,主要是由於新產品開發的成長。

從配銷通路細分來看,醫院藥房是2022年的主導類型,主要是由於住院患者的需求不斷成長。

從地區來看,由於醫療基礎設施的改善,北美將成為 2022 年的主要收入來源。

抗感染劑市場細分分析:

全球抗感染藥物市場根據類型、給藥途徑、配銷通路和地區進行細分。

市場依類型分為三類:抗菌、抗病毒和抗真菌。抗病毒藥物領域佔據市場主導地位。抗病毒藥物需求的增加預計將推動未來幾年抗病毒藥物的需求。

依給藥途徑,市場分為三類:外用、口服、靜脈注射。口腔細分市場在市場上佔據主導地位,並可能在預測期內保持其主導地位。這部分是由於人們越來越關注減少口服療法。

根據配銷通路,市場分為四類:醫院藥房、零售藥房、電子商務等。醫院藥房在市場上佔據主導地位,並可能在預測期內保持其主導地位。這是由於醫院患者治療的高需求正在推動市場成長。

抗感染藥物市場-地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

抗感染劑市場-競爭格局:

市場參與者正在增加產品範圍、研發投資和產品組合擴張,以此作為鞏固其產業地位的策略。科學、生物技術和藥物研究的發展有助於新型抗感染藥物的研發。它需要確定新的藥物靶點,創造尖端的藥物傳遞方法,並採用尖端的診斷方法來更準確地診斷疾病。預計這些因素將為公司之間的市場成長提供良性競爭。

最近的發展:

2022 年 1 月,Mankind Pharma 推出了 Savior Mankind,其部門專注於開發用於拯救生命的注射藥物。其產品組合包括抗感染藥物等多種治療解決方案。

目錄

第 1 章:抗感染藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按類型分類的抗感染劑市場片段
    • 按給藥途徑分類的抗感染藥物市場片段
    • 按配銷通路分類的抗感染劑市場片段
    • 按國家/地區分類的抗感染藥物市場片段
    • 按地區分類的抗感染藥物市場片段
  • 競爭洞察

第 3 章:抗感染藥物主要市場趨勢

  • 抗感染劑市場促進因素
    • 市場促進因素的影響分析
  • 抗感染藥物市場限制
    • 市場限制影響分析
  • 抗感染劑市場機會
  • 抗感染劑市場未來趨勢

第 4 章:抗感染藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:抗感染藥物市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:抗感染藥物市場格局

  • 2022 年抗感染藥物市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:抗感染藥物市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 抗菌
    • 抗病毒劑
    • 抗真菌劑

第 8 章:抗感染藥物市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 專題
    • 口服
    • 靜脈

第 9 章:抗感染藥物市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 電子商務
    • 其他

第 10 章:抗感染藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美抗感染劑主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按類型)
    • 北美市場規模與預測(按管理途徑)
    • 北美市場規模和預測(按配銷通路)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲抗感染劑主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模與預測(按類型)
    • 歐洲市場規模與預測(按管理途徑)
    • 歐洲市場規模和預測(按配銷通路)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區抗感染藥物主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按類型)
    • 亞太地區市場規模與預測(依管理途徑)
    • 亞太地區市場規模和預測(按配銷通路)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲抗感染藥物主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按類型)
    • 拉丁美洲市場規模與預測(按管理途徑)
    • 拉丁美洲市場規模和預測(按配銷通路)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲抗感染劑主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按類型)
    • 中東和非洲市場規模及預測(按管理途徑)
    • 中東和非洲市場規模及預測(按配銷通路)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章:主要供應商分析 - 抗感染藥物產業

  • 競爭儀表板
  • 公司簡介
    • Novartis
    • GSK
    • Pfizer Inc.
    • Abbott.
    • Gilead Sciences, Inc.
    • Bristol-Myers Squibb Company
    • Merck & Co., Inc.
    • Sandoz International GmbH
    • B. Braun SE
    • Xellia Pharmaceuticals
    • Mankind Pharma
    • Bayer AG
    • AstraZeneca
    • Boehringer Ingelheim International GmbH
    • Others

第 12 章:360 度分析師視角

第 13 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1989

REPORT HIGHLIGHT

Anti-Infective Agents Market size was valued at USD 1,37,461.03 Million in 2022, expanding at a CAGR of 4.2% from 2023 to 2030.

Anti-infectives, such as antibacterials, antivirals, antifungals, and antiparasitic drugs, are treatments that prevent or treat infections. Pre-clinical and clinical research on antimicrobials, antibacterials, antivirals, antifungals, and antiparasitic drugs is included in the category of anti-infective agents.

Anti-Infective Agents Market- Market Dynamics

Increasing prevalence of infectious disease and health consciousness to propel market demand

The Anti-Infective Agents market is also expected to increase as a result of growing health consciousness regarding the availability of infectious illness diagnostics and the preventable risks associated with early diagnosis. Infectious disorders, such as bacterial, viral, and fungal infections, continue to affect more people worldwide. To fight these illnesses, there is now a greater need for potent anti-infective medications. Effective anti-infective drugs are becoming more and more necessary because of the advent of novel infectious diseases or the resurgence of old ones. Some instances of these illnesses are the COVID-19 pandemic that occurred more recently, as well as the Ebola and Zika outbreaks. These incidents demonstrate how urgent it is to create and implement efficient remedies to control and treat these illnesses.

Anti-Infective Agents Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.2% over the forecast period (2023-2030)

Based on Type segmentation, antiviral was predicted to show maximum market share in the year 2022, owing to growing antiviral drug developments.

Based on Route of Administration segmentation, oral segment was the leading type in 2022, mainly due to rise in new product development.

Based on Distribution Channel segmentation, hospital pharmacies was the leading type in 2022, mainly due to growing demand from hospitalized patients.

On the basis of region, North America was the leading revenue generator in 2022, owing to improved healthcare infrastructure.

Anti-Infective Agents Market- Segmentation Analysis:

The Global Anti-Infective Agents Market is segmented on the basis of Type, Route of Administration, Distribution Channel, and Region.

The market is divided into three categories based on Type: antibacterial, antiviral, and antifungal. The antiviral segment dominates the market. The increased demand for antiviral drugs is expected to boost the demand for antiviral agents in the coming years.

The market is divided into three categories based on Route of Administration: topical, oral, intravenous. The oral segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to the growing focus on reducing oral therapies.

The market is divided into four categories based on Distribution Channel: hospital pharmacies, retail pharmacies, e-commerce, and others. The hospital pharmacies dominate the market and is likely to maintain its dominance during the forecast period. This is due to high demand patient treatment in hospitals is boosting the market growth.

Anti-Infective Agents Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Anti-Infective Agents Market- Competitive Landscape:

Market players are increasing the range of products offered, R&D investments, and portfolio expansions as tactics to fortify their positions in the industry. Scientific, biotechnological, and pharmaceutical research developments have aided in the creation of novel anti-infective drugs. It entails identifying fresh targets for drugs, creating cutting-edge drug delivery methods, and employing cutting-edge diagnostic methods to diagnose illnesses more precisely. These factors ere expected to provide healthy competition among companies for market growth.

Recent Developments:

In January 2022, Mankind Pharma launched Saviour Mankind, its division focused on development of injectable medications for life-saving purposes. Its product portfolio includes a wide range of therapeutic solutions, from anti-infective agents.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTI-INFECTIVE AGENTS MARKET KEY PLAYERS

  • Novartis
  • GSK
  • Pfizer Inc.
  • Abbott.
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sandoz International GmbH
  • B. Braun SE
  • Xellia Pharmaceuticals
  • Mankind Pharma
  • Bayer AG
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Others

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY TYPE

  • Antibacterial
  • Antiviral
  • Antifungal

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY ROUTE OF ADMINISTRATION

  • Topical
  • Oral
  • Intravenous

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY DISTRIBUTION CHANNEL

  • Hospital pharmacies
  • Retail pharmacies
  • E-commerce
  • Others

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Anti-Infective Agents Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Anti-Infective Agents Market Snippet by Type
    • 2.1.2. Anti-Infective Agents Market Snippet by Route of Administration
    • 2.1.3. Anti-Infective Agents Market Snippet by Distribution Channel
    • 2.1.4. Anti-Infective Agents Market Snippet by Country
    • 2.1.5. Anti-Infective Agents Market Snippet by Region
  • 2.2. Competitive Insights

3. Anti-Infective Agents Key Market Trends

  • 3.1. Anti-Infective Agents Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Anti-Infective Agents Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Anti-Infective Agents Market Opportunities
  • 3.4. Anti-Infective Agents Market Future Trends

4. Anti-Infective Agents Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Anti-Infective Agents Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Anti-Infective Agents Market Landscape

  • 6.1. Anti-Infective Agents Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Anti-Infective Agents Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Antibacterial
    • 7.1.3. Antiviral
    • 7.1.4. Antifungal

8. Anti-Infective Agents Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Topical
    • 8.1.3. Oral
    • 8.1.4. Intravenous

9. Anti-Infective Agents Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital pharmacies
    • 9.1.3. Retail pharmacies
    • 9.1.4. E-commerce
    • 9.1.5. Others

10. Anti-Infective Agents Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Anti-Infective Agents Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Anti-Infective Agents Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Anti-Infective Agents Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Anti-Infective Agents Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Anti-Infective Agents Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Anti-Infective Agents Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Novartis
    • 11.2.2. GSK
    • 11.2.3. Pfizer Inc.
    • 11.2.4. Abbott.
    • 11.2.5. Gilead Sciences, Inc.
    • 11.2.6. Bristol-Myers Squibb Company
    • 11.2.7. Merck & Co., Inc.
    • 11.2.8. Sandoz International GmbH
    • 11.2.9. B. Braun SE
    • 11.2.10. Xellia Pharmaceuticals
    • 11.2.11. Mankind Pharma
    • 11.2.12. Bayer AG
    • 11.2.13. AstraZeneca
    • 11.2.14. Boehringer Ingelheim International GmbH
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Anti-Infective Agents Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Anti-Infective Agents Market, by Type 2018-2030 (USD Million)
  • TABLE Anti-Infective Agents Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Anti-Infective Agents Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Anti-Infective Agents Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Anti-Infective Agents Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Anti-Infective Agents Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Anti-Infective Agents Market, by Region 2018-2030 (USD Million)
  • TABLE North America Anti-Infective Agents Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Anti-Infective Agents Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Anti-Infective Agents Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Anti-Infective Agents Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Anti-Infective Agents Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Anti-Infective Agents Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Anti-Infective Agents Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Anti-Infective Agents Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-Infective Agents Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-Infective Agents Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-Infective Agents Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-Infective Agents Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Anti-Infective Agents Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Anti-Infective Agents Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Anti-Infective Agents Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Anti-Infective Agents Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-Infective Agents Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-Infective Agents Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-Infective Agents Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-Infective Agents Market, by Distribution Channel, 2018-2030 (USD Million)